Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3185058

Beta release

Statistics of Selinexor in patients with relapsed or refractory diffuse large B -cell lymphoma (SADAL): a single -arm, multinational, multicentre, open -label, phase 2 trial
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0700
2024-0800
2024-0900